{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/20/3276869/0/en/Pasithea-Therapeutics-Announces-Grant-of-Rare-Pediatric-Disease-Designation-RPDD-by-FDA-to-PAS-004-for-Treatment-of-Neurofibromatosis-Type-1-NF1.html", "message": "News view counter 671002 successfully enlarged"}